Erythromycin (ERY-TAB)
Macrolide class · 15 generic manufacturers · 34 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Erythromycin used for?
Erythromycin is a Macrolide medication tracked in Medicare Part D.
Is there a generic for Erythromycin?
Yes. 34 ANDAs filed at FDA, 15 generic manufacturers currently shipping.
How much does my plan pay for Erythromycin?
Across 329 Part D plans, Erythromycin averages $1.42/unit (NADAC). Lowest available: $0.348/unit. Highest in distribution: $2.48/unit.
Is Erythromycin on the FDA shortage list?
No. Erythromycin is not currently on the FDA Drug Shortage Database.
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.